Enolase of Streptococcus Suis Serotype 2 Enhances Blood–Brain Barrier Permeability by Inducing IL-8 Release

Inflammation

Volumn 39, Issue 2, 2016, Pages 718-726

  Sun, Yingying ^a   Li, Na ^a   Zhang, Jing ^b   Liu, Hongtao ^a   Liu, Jianfang ^a   Xia, Xiaojing ^a   Sun, Changjiang ^a   Feng, Xin ^a   Gu, Jingmin ^a   Du, Chongtao ^a   Han, Wenyu ^a   Lei, Liancheng ^a  

^a JILIN UNIVERSITY   (China)

^b CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

blood brain barrier; enolase; meningitis; streptococcus suis serotype 2

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; ENOLASE; EVANS BLUE; G 31P; INTERLEUKIN 8; UNCLASSIFIED DRUG; CXCL8(3-73)K11R,G31P, BOVINE; PEPTIDE FRAGMENT; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN LEVEL; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MENINGITIS; MOUSE; NONHUMAN; PIG; STREPTOCOCCUS SUIS; STREPTOCOCCUS SUIS SEROTYPE 2; ANIMAL; BAGG ALBINO MOUSE; CAPILLARY PERMEABILITY; CELL CULTURE; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; METABOLISM; MOLECULAR CLONING; PATHOGENICITY; PATHOPHYSIOLOGY; SECRETION (PROCESS); VASCULAR ENDOTHELIUM;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CELLS, CULTURED; CLONING, MOLECULAR; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; INTERLEUKIN-8; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; PHOSPHOPYRUVATE HYDRATASE; STREPTOCOCCUS SUIS; SWINE; VIRULENCE FACTORS;

EID: 84953316258     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0298-7     Document Type: Article

References (38)

1. Gottschalk, M., M. Segura, and J. Xu. 2007. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Animal Health Research Reviews 8: 29–45.
2. Wertheim, H.F., H.D. Nghia, W. Taylor, and C. Schultsz. 2009. Streptococcus suis: an emerging human pathogen. Clinical Infectious Diseases 48: 617–62.
3. Vanier, G., M. Segura, P. Friedl, S. Lacouture, and M. Gottschalk. 2004. Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infection and Immunity 72: 1441–1449.
4. Pancholi, V. 2001. Multifunctional alpha-enolase: its role in diseases. Cellular and Molecular Life Sciences 58: 902–920.
5. Zhang, E., J.M. Brewer, W. Minor, L.A. Carreira, and L. Lebioda. 1997. Mechanism of enolase: the crystal structure of asymmetric dimer enolase-2-phospho-D-glycerate/enolase-phosphoenolpyruvate at 2.0 A resolution. Biochemistry 36: 12526–12534.
6. Piast, M., I. Kustrzeba-Wojcicka, M. Matusiewicz, and T. Banas. 2005. Molecular evolution of enolase. Acta Biochimica Polonica 52: 507–513.
7. Vanier, G., M. Segura, P. Friedl, S. Lacouture, and M. Gottschalk. 2004. Enolase from Streptococcus sobrinus is an immunosuppressive protein. Cellular Microbiology 6: 79–88.
8. Chhatwal, G.S. 2002. Anchorless adhesins and invasins of Gram-positive bacteria: a new class of virulence factors. Trends in Microbiology 10: 205–208.
9. Esgleas, M., Y. Li, M.A. Hancock, J. Harel, J.D. Dubreuil, and M. Gottschalk. 2008. Isolation and characterization of alpha-enolase, a novel fibronectin-binding protein from Streptococcus suis. Microbiology 154: 2668–2679.
10. Capello, M., S. Ferri-Borgogno, P. Cappello, and F. Novelli. 2011. alpha-Enolase: a promising therapeutic and diagnostic tumor target. The FEBS Journal 278: 1064–1074.
11. Chang, G.C., K.J. Liu, C.L. Hsieh, T.S. Hu, S. Charoenfuprasert, H.K. Liu, K.T. Luh, et al. 2006. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer 5: 161.
12. Feo, S., D. Arcuri, E. Piddini, R. Passantino, and A. Giallongo. 2000. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Letters 473: 47–52.
13. Ghosh, A.K., R. Steele, and R.B. Ray. 2005. c-myc Promoter-binding protein 1 (MBP-1) regulates prostate cancer cell growth by inhibiting MAPK pathway. The Journal of Biological Chemistry 280: 14325–14330.
14. Chang, G.C., K.J. Liu, C.L. Hsieh, T.S. Hu, S. Charoenfuprasert, H.K. Liu, K.T. Luh, et al. 2006. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clinical Cancer Research 12: 5746–5754.
15. Ucker, D.S., M.R. Jain, G. Pattabiraman, K. Palasiewicz, R.B. Birge, and H. Li. 2012. Externalized glycolytic enzymes are novel, conserved, and early biomarkers of apoptosis. The Journal of Biological Chemistry 287: 10325–10343.
16. Yang, H.B., W.J. Zheng, X. Zhang, and F.L. Tang. 2011. Induction of endothelial cell apoptosis by anti-alpha-enolase antibody. Chinese Medical Sciences Journal 26: 152–157.
17. Lopez-Alemany, R., C. Longstaff, S. Hawley, M. Mirshahi, P. Fabregas, M. Jardi, E. Merton, et al. 2003. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase. American Journal of Hematology 72: 234–242.
18. Miles, L.A., C.M. Dahlberg, J. Plescia, J. Felez, K. Kato, and E.F. Plow. 1991. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 30: 1682–1691.
19. Redlitz, A., B.J. Fowler, E.F. Plow, and L.A. Miles. 1995. The role of an enolase-related molecule in plasminogen binding to cells. European Journal of Biochemistry 227: 407–415.
20. Dudani, A.K., C. Cummings, S. Hashemi, and P.R. Ganz. 1993. Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thrombosis Research 69: 185–196.
21. Abbott, N.J., L. Ronnback, and E. Hansson. 2006. Astrocyte-endothelial interactions at the blood–brain barrier. Nature Reviews Neuroscience 7: 41–53.
22. Dejana, E., M. Corada, and M.G. Lampugnani. 1995. Endothelial cell-to-cell junctions. The FASEB Journal 9: 910–918.
23. Gaillard, P.J., L.H. Voorwinden, J.L. Nielsen, A. Ivanov, R. Atsumi, H. Engman, C. Ringbom, et al. 2001. Establishment and functional characterization of an in vitro model of the blood–brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. European Journal of Pharmaceutical Sciences 12: 215–222.
24. Wolburg, H., J. Neuhaus, U. Kniesel, B. Krauss, E.M. Schmid, M. Ocalan, C. Farrell, et al. 1994. Modulation of tight junction structure in blood–brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. Journal of Cell Science 107(Pt 5): 1347–1357.
25. Utepbergenov, D.I., K. Mertsch, A. Sporbert, K. Tenz, M. Paul, R.F. Haseloff, and I.E. Blasig. 1998. Nitric oxide protects blood–brain barrier in vitro from hypoxia/reoxygenation-mediated injury. FEBS Letters 424: 197–201.
26. Rubin, L.L., D.E. Hall, S. Porter, K. Barbu, C. Cannon, H.C. Horner, M. Janatpour, et al. 1991. A cell culture model of the blood–brain barrier. The Journal of Cell Biology 115: 1725–1735.
27. Hurwitz, A.A., J.W. Berman, W.K. Rashbaum, and W.D. Lyman. 1993. Human fetal astrocytes induce the expression of blood–brain barrier specific proteins by autologous endothelial cells. Brain Research 625: 238–243.
28. Megard, I., A. Garrigues, S. Orlowski, S. Jorajuria, P. Clayette, E. Ezan, and A. Mabondzo. 2002. A co-culture-based model of human blood–brain barrier: application to active transport of indinavir and in vivo-in vitro correlation. Brain Research 927: 153–167.
29. Epiphanio, S., M.G. Campos, A. Pamplona, D. Carapau, A.C. Pena, R. Ataide, C.A. Monteiro, et al. 2010. VEGF promotes malaria-associated acute lung injury in mice. PLoS Pathogens 6, e1000916.
30. Scott, P.A., and R. Bicknell. 1993. The isolation and culture of microvascular endothelium. Journal of Cell Science 105(Pt 2): 269–273.
31. DeBault, L.E., and P.A. Cancilla. 1980. Some properties of isolated endothelial cells in culture. Advances in Experimental Medicine and Biology 131: 69–78.
32. Walters, E.M., Y. Agca, V. Ganjam, and T. Evans. 2011. Animal models got you puzzled?: think pig. Annals of the New York Academy of Sciences 1245: 63–64.
33. Bendixen, E., M. Danielsen, K. Larsen, and C. Bendixen. 2010. Advances in porcine genomics and proteomics—a toolbox for developing the pig as a model organism for molecular biomedical research. Briefings in Functional Genomics 9: 208–219.
34. Lunney, J.K. 2007. Advances in swine biomedical model genomics. International Journal of Biological Sciences 3: 179–184.
35. Bernal, D., J.E. de la Rubia, A.M. Carrasco-Abad, R. Toledo, S. Mas-Coma, and A. Marcilla. 2004. Identification of enolase as a plasminogen-binding protein in excretory-secretory products of Fasciola hepatica. FEBS Letters 563: 203–206.
36. Sundstrom, P., and G.R. Aliaga. 1992. Molecular cloning of cDNA and analysis of protein secondary structure of Candida albicans enolase, an abundant, immunodominant glycolytic enzyme. Journal of Bacteriology 174: 6789–6799.
37. Asano, T., K. Ichiki, S. Koizumi, K. Kaizu, T. Hatori, O. Fujino, K. Mashiko, Y. Sakamoto, T. Miyasho, and Y. Fukunaga. 2010. IL-17 is elevated in cerebrospinal fluids in bacterial meningitis in children. Cytokine 51: 101–106.
38. Doran, K.S., G.Y. Liu, and V. Nizet. 2003. Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. The Journal of Clinical Investigation 112: 736–744.